Mark Neumann, EVP, Chief Commercial Officer: Intra-Cellular Therapies ITCI Sell · Filed 23/02/22

Trade details

Type: Insider sale
Amount: $146,355.4
Shares · price: 3,140 sh · $46.61 a share
Held after: 53,338 sh
Stock: Intra-Cellular Therapies ITCI
Person: Mark NeumannEVP, Chief Commercial Officer
Trade date: 23/02/21
Filed: 23/02/22
Days to filing: 1 days

Sold 5.6% of holdings

Share of holding sold: 5.6%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/01/22~23/03/23

Mark Neumann's recent trades

Mark NeumannEVP, Chief Commercial Officer
SellIntra-Cellular Therapies
Sell
Intra-Cellular Therapies
ITCI
$1.4M
18,714 sh
$1.4M
Filed 24/08/20
Traded 24/08/16
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$573.2K
8,636 sh
$573.2K
Filed 24/03/11
Traded 24/03/07
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$301K
4,496 sh
$301K
Filed 24/03/11
Traded 24/03/07
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$280.2K
4,303 sh
$280.2K
Filed 24/03/11
Traded 24/03/11
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$114K
1,729 sh
$114K
Filed 24/03/11
Traded 24/03/11

Mark Neumann, Chief Officer — sold $146.4K of Intra-Cellular Therapies ITCI · 5.6% of holdings | Whalegun